Imprint
Information in accordance with Section 5 (1), Austrian E-Commerce Act (ECG) and Section 25, Austrian Media Law:
Responsible for content:
MARK53 GesmbH
c/o Univ.Prof.Dr. Daniela Kandioler
Saarplatz 3
1190 Wien
T 43 (0)664 94 70 290
F +43 (0)1 2533033 5540
E-Mail: office@mark53.at
www.mark53.com
Web design:
www.graphiks.info
Copyright – Notice
Content, design and data on this website is subject to copyright.
Content may only be reproduced with the formal consent of MARK53
ABOUT 
With the Mark53 analysis, our company is making available a precise p53 gene test, which – for the first time – establishes the prerequisites for a broad clinical application of this biomarker. For the question, as to which patient responds to a cancer therapy and which does not, is a crucial one! We wish to pave the way for an efficient cancer therapy and continue to guarantee research that is independent of the pharmaceutical industry.